Skip to main content


Herbal formula YGJDSJ inhibits anchorage-independent growth and induces anoikis in hepatocellular carcinoma Bel-7402 cells



Based on clinical medications and related studies, we established a Yang-Gan Jie-Du Sang-Jie (YGJDSJ) herbal formula for hepatocarcinoma treatment. In present study, we evaluated the anti-cancer potential of YGJDSJ on suspension-grown human hepatocellular carcinoma Bel-7402 cells.


Bel-7402 cells were cultured in poly(2-hydroxyethyl methacrylate) (poly-HEMA) coated plates and treated with YGJDSJ. Anchorage-independent cell growth was detected by cell Counting Kit-8 (CCK-8) assay and soft agar colony formation assay. Anoikis was detected by ethdium homodimer-1 (EthD-1) staining and flow cytometry analysis. Caspases activities were detected by the cleavage of chromogenic substrate. Reactive oxygen species (ROS) was detected by 2′,7′-dichlorofluorescin diacetate (DCFH-DA) staining. Protein expression and phosphorylation was identified by western blot. Protein expression was knocked-down by siRNA.


YGJDSJ inhibited the proliferation of Bel-7402 cells in poly-HEMA coated plates and anchorage-independent growth of Bel-7402 cells in soft agar. YGJDSJ also induced anoikis in Bel-7402 cells as indicated by EthD-1 staining and flow cytometry analysis. YGJDSJ activated caspase-3, − 8, and − 9 in suspension-grown Bel-7402 cells. The pan-caspase inhibitor Z-VAD-FMK significantly abrogated the effects of YGJDSJ on anoikis in suspension-grown Bel-7402 cells. In addition, YGJDSJ increased ROS in suspension-grown Bel-7402 cells. The ROS scavenger N-acetyl-L-cysteine (NAC) partially attenuated YGJDSJ-induced activation of caspase-3, − 8 and − 9 and anoikis in suspension-grown Bel-7402 cells. Furthermore, YGJDSJ inhibited expression and phosphorylation of protein tyrosine kinase 2 (PTK2) in suspension-grown Bel-7402 cells. Over-expression of PTK2 significantly abrogated YGJDSJ induced anoikis.


YGJDSJ inhibits anchorage-independent growth and induce caspase-mediated anoikis in Bel-7402 cells, and may relate to ROS generation and PTK2 downregulation.


Hepatocarcinoma is one of the most common malignancies worldwide, and ranks second and sixth as the cause of cancer deaths in men and women, respectively [1]. The treatment options for hepatocarcinoma mostly include surgery, transhepatic artery chemoembolization (TACE), and targeted therapy. Surgery, comprising either hepatectomy and/or liver transplantation, is the only treatment that can possibly cure hepatocarcinoma. However, only patients with early-stage hepatocarcinoma are eligible for curative surgery. The prognosis for patients with middle and advanced stages of hepatocarcinoma, especially metastatic hepatocarcinoma, remains poor [2, 3]. Hepatocarcinomas tend to metastasize to the lungs, bones, adrenal glands, and other distant organs via blood circulation. Hepatocarcinomas can also metastasize to the lymph nodes via circulating lymph, including portal lymph nodes, periaortic lymph nodes, and supraclavicular lymph nodes [4, 5]. Cancer metastasis is closely associated with anoikis resistance [6, 7].

Anoikis, also known as detachment-induced apoptosis, is the programmed cell death of epithelial cells (including cancer cells) following their detachment from the extracellular matrix (ECM) [8]. Anoikis was first discovered by Frisch and Francis in 1994 [9]. Cancer cells possess a certain degree of resistance to anoikis due to abnormal gene expression or activity that enables them to survive in circulating blood, lymph, or other liquid media, and this ultimately causes metastasis in distant tissues [6, 10]. However, cancer cells can undergo anoikis upon appropriate drug treatment. For example, fucoxanthinol, 5-azacytidine and foretinib can promote anoikis in cancer cells via different mechanisms [11,12,13]. Promoting cancer cell anoikis has become an important strategy for preventing cancer metastasis [14, 15].

Traditional Chinese medicine (TCM) is an important biomedical resource and plays important role in the treatment of hepatocarcinoma [16]. Based on clinical medications and TCM principles, we have established a herbal formula, Yang-Gan Jie-Du Sang-Jie (YGJDSJ), for hepatocarcinoma treatment. YGJDSJ comprises several Chinese herbs including the fruits of Ligustrum lucidum Ait. (Nü-zhen-zi), Duchesnea indica (Andr.) Focke (She-Mei), Solanum nigrum L. (Long-Kui), Euphorbia helioscopia L. (Ze-Qi), the root of Ranunculus ternatus Thunb. (Mao-Zhua-Cao), the root of Curcuma wenyujin Y. H. Chen et C. Ling (Yü-Jin) and the root of Polygonum cuspidatum Sieb. et Zucc. (Hu-Zhang). Most herbs in YGJDSJ have demonstrated anti-cancer effects in various cancer cells [16, 17]. In the present study, the effects and possible mechanism of YGJDSJ on anchorage-independent growth and anoikis of hepatocarcinoma cells were evaluated.


Chemicals and reagents

DMEM medium and fetal bovine serum was obtained from Hyclone (Logan, UT). Cell Counting Kit-8 (CCK8) was from Dojindo (Kumamoto, Japan). Caspases activities detection kits, 2′,7′-dichlorofluorescin diacetate (DCFH-DA), and N-acetyl-L-cysteine (NAC) were purchased from Beyotime (Haimen, China). Z-VAD-FMK was from R&D Systems (Minneapolis, MN). Antibodies against protein tyrosine kinase 2/focal adhesion kinase (PTK2/FAK), p-PTK2 and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were the product of Cell Signaling Technology (Danvers, MA). Poly(2-hydroxyethyl methacrylate) (poly-HEMA) was produced by Sigma-Aldrich (St. Louis, MO). CytoSelect™ 24-Well Anoikis Assay kit was provided by Cell Biolabs (San Diego, CA). Caspase-3, 8 and 9 activity assay kits were provided by Beyotime Institute of Biotechnology (Haimen, China).

Cell culture

Human hepatocellular carcinoma Bel-7402 cells were obtained from Cell Bank of Type Culture Collection of Chinese Academy of Sciences. Bel-7402 cells were grown in DMEM medium with 10% FBS and 1% Pen-Strep, and maintained at a 37 °C in a humidified incubator with a 5% CO2 atmosphere. All the cell treatment was did in 10% FBS condition.

Herb preparation

The main herbs in YGJDSJ formula (Chinese patent ZL201110145109.0) are the fruits of L. lucidum Ait. (Nü-zhen-zi) 12 g, D. indica (Andr.) Focke (She-Mei) 15 g, S. nigrum L. (Long-Kui) 15 g, Scutellaria barbata D. Don (Ban-Zhi-Lian) 30 g, E. helioscopia L. (Ze-Qi) 15 g, the root of R. ternatus Thunb. (Mao-Zhua-Cao) 15 g, the root of C. wenyujin Y. H. Chen et C. Ling (Yü-Jin) 15 g and the root of P. cuspidatum Sieb. et Zucc. (Hu-Zhang) 15 g. The doses of these herbs were based on clinical medication.

All those herbs were from Longhua Hospital according to the original proportion. Herb extraction was performed as described previously [18, 19]. Briefly, herbs were extracted twice with an 8-fold volume of boiling distilled water for 1 h and the aqueous extracts were collected. The collected aqueous extracts were combined, filtered, centrifuged twice at 12,000 rpm for 30 min at 4 °C, and the supernatants were collected. The supernatants were then mixed with an equal volume of ethanol and kept at 4 °C overnight, centrifuged at 12,000 rpm for 30 min at 4 °C and the supernatants were collected and lyophilized. Subsequently, the ethanol extracts were dissolved in DMEM medium (400 mg/ml), sequentially passed through 0.45 μm and 0.22 μm filters for sterilization, and stored at − 20 °C until further use.

Anchorage-independent growth assay

Poly-HEMA, a non-toxic polymer of 2-hydroxyethyl methacrylate, was used for anchorage-independent cell growth in vitro because of its ability to reduce the adhesivity of plastic cell culture plates. Bel-7402 cells in logarithmic growth phase were seeded into poly-HEMA coated 96-well plate (8 × 103 cells/well). After 24 h cells were exposed to various doses of YGJDSJ or equal volume of DMEM for 24 h, and cell viability was evaluated by using the CCK-8 assay according to the manufacturer’s instructions. The cell survival rate was calculated as follows: cell survival rate (%) = (experimental OD value/control OD value) × 100%.

For the soft agar colony formation assays, 2 × 104 log-phase Bel-7402 cells were seeded and grown on a plate containing 1% base agar and 0.6% top agar, and exposed to different concentrations of YGJDSJ or equal volume of DMEM twice a week for 2 weeks and incubated at 37 °C in a humidified incubator with a 5% CO2 atmosphere. Colonies were stained with crystal violet a counted under a dissecting microscope. The inhibition of colony formation was calculated as follows: inhibition (%) = [(control colonies - experimental colonies)/control colonies] × 100%.

Anoikis assay

Anoikis was detected by CytoSelect™ 24-Well Anoikis Assay kit according to the manufacturer’s instructions. Briefly, log-phase Bel-7402 cells (4 × 104 cells/well) were inoculated in poly-HEMA coated 24-well plate. On the second day, the cells were exposed to different dose of YGJDSJ or equal volume of DMEM for 24 h, and stained with ethidium homodimer (EthD-1) at 37 °C for 1 h. The presence of red EthD-1 fluorescence was monitored under a fluorescence microscope and measured with a fluorescence microplate reader (excitation wavelength 525 nm, emission wavelength 590 nm). EthD-1 is a high-affinity fluorescent nucleic acid dye, which can only penetrate membrane damaged dead cells and produces red fluorescence upon binding to nucleic acids, and thus be used to detect cell death in suspension (anoikis).

Flow cytometric analysis

For apoptosis identification, 2 × 105 log-phase Bel-7402 cells were seeded in poly-HEMA coated 6-well plate. On the second day, cells were treated with different concentrations of YGJDSJ or equal volume of DMEM for 24 h. YGJDSJ treated Bel-7402 cells were collected, stained with Annexin V-FITC and PI as recommended by the manufacturer, and detected in a FACScalibour flow cytometer (Becton Dickinson).

Caspase activity assay

After treatment with different concentration of YGJDSJ, caspase-3, 8 and 9 activities were measured by the cleavage of the specific chromogenic substrate Ac-DEVD-pNA, Ac-IETD-pNA and Ac-LEHD-pNA respectively. The cleavaged yellow pNA are positive correlation with caspase-3, 8 and 9 activities. The presence of yellow pNA was detected with a microplate reader at a wavelength of 405 nm. The results are expressed as the fold change in comparison with the control group. For caspases inhibition, Bel-7402 cells pretreated with Z-VAD-FMK (50 μmol/L, 2 h) were incubated with YGJDSJ for another 24 h.

Measurement of intracellular reactive oxygen species (ROS)

Intracellular ROS production was detected by DCFH-DA staining. DCFH-DA is cleaved intracellularly by nonspecific esterases to form DCFH, which is further oxidized by ROS to form the fluorescent compound DCF [20]. Log-phase Bel-7402 cells (4 × 104 cells/well) were seeded in poly-HEMA coated 24-well plate. On the second day, the cells were exposed to different dose of YGJDSJ or equal volume of DMEM for 24 h, and stained with DCFH-DA at 37 °C for 20 min in the dark. The presence of DCF fluorescence was observed under a fluorescence microscope and quantitated with a fluorescence microplate reader at excitation wavelength of 488 nm and emission wavelength of 525 nm. For ROS inhibition, cells were pretreated with NAC (50 mmol/L for 2 h), followed by desired YGJDSJ treatment.

Western blot

Western blots were performed as described previously [21, 22]. Briefly, collected cells were lysed and subjected to 8–12% SDS-PAGE, and transferred onto a nitrocellulose membrane (Amersham Biosciences, Buckinghamshire, UK). The transferred membrane were blocked with 5% non-fat milk, washed, and probed with the indicated antibodies. Blots were then washed and incubated with IRDye 700- or IRDye 800-conjugated secondary antibodies (Rockland Immunochemicals, Gilbertsville, PA, USA), and visualized in Odyssey Infrared Imaging System (LI-COR Biosciences, Lincoln, NE, USA).

Plasmid transfection

For plasmid transfection, Bel-7402 cells were cultured on 6-well plate to 90–95% confluence, and 4.0 μg recombinant human PTK2 eukaryotic expression plasmid or control empty vector (Genechem, Shanghai, China) were introduced into the cells by Lipofectamine™ 2000 according to the manufacturer’s recommendations. After 24 h of transfection, cells were subjected to suspension-culture, YGJDSJ (200 μg/ml) treatment for 24 h, western blot and anoikis assay.

Statistical analyses

Results are expressed as means ± standard deviation of at least two independent experiments, each conducted in triplicate. Differences between control and YGJDSJ treatment were analyzed by one-way ANOVA. Differences were considered significant at P ≤ 0.05.


YGJDSJ inhibits anchorage-independent growth of Bel-7402 cells

Poly-HEMA-coated culture plates were used to observe the effects of YGJDSJ on anchorage-independent growth in Bel-7402 cells. The results show that YGJDSJ inhibited proliferation of Bel-7402 cells in the poly-HEMA coated plates in a dose-dependent manner (P < 0.01) (Fig. 1a).

Fig. 1

YGJDSJ inhibited anchorage-independent growth of Bel-7402 cells. a Bel-7402 cells were cultured in poly-HEMA coated 96-well plate and treated with different concentrations of YGJDSJ for 24 h, cell viability was evaluated by CCK-8 assay. b Bel-7402 cells were treated with different dose of YGJDSJ twice a week for 2 weeks in soft-agar colony formation assay. Data shown are representative of three independent experiments. *P < 0.01, versus control group

The effects of YGJDSJ on long-term anchorage-independent Bel-7402 cell growth were further observed using soft agar colony formation assays. The results show that YGJDSJ inhibits colony formation of Bel-7402 cells in a dose-dependent manner (P < 0.01) (Fig. 1b). These observations suggest that YGJDSJ can inhibit anchorage-independent growth in Bel-7402 cells.

YGJDSJ induces anoikis in Bel-7402 cells

Anoikis in Bel-7402 cells was detected with a commercial kit, in which the 24-well culture plate was coated with poly-HEMA, and EthD-1 fluorescence labeling was used for anoikis detection. The results show that after YGJDSJ treatment, Bel-7402 cells absorbed EthD-1 and emitted red fluorescence, which suggesting YGJDSJ induced anoikis in Bel-7402 cells (Fig. 2a and b). Further Annexin V-FITC/PI double labeling and flow cytometry analysis confirmed that YGJDSJ significantly induced apoptosis in suspension-grown Bel-7402 cell in a dose-dependent manner (P < 0.01) (Fig. 2c and d). These results suggest that YGJDSJ induced anoikis in Bel-7402 cells.

Fig. 2

YGJDSJ induced anoikis in Bel-7402 cells. Suspension-grown Bel-7402 cells were treated with different dose of YGJDSJ for 24 h, stained with EthD-1, and observed under fluorescence microscope (× 200) (a), and quantitated with a fluorescence microplate reader (b). YGJDSJ treated or untreated Bel-7402 cells were stained with Annexin V-FITC/PI, analyzed in FACScalibour flow cytometer (c), and expressed as mean ± SD (d). Data illustrated are from three separate experiments. *P < 0.01, versus control group

YGJDSJ activates caspase activity in Bel-7402 cells

Similar to that in apoptosis, anoikis is also mediated by the caspase cascade [6, 10, 23]. In this study, the effects of YGJDSJ herbs on caspase activity were detected by commercial kits. As shown in Fig. 3, YGJDSJ significantly activated caspase-3, − 8, and − 9 in suspension-grown Bel-7402 cells in a dose-dependent manner (P < 0.01) (Fig. 3a-c). In addition, Z-VAD-FMK, a pan-caspase inhibitor, significantly abrogated the effect of YGJDSJ on anoikis (P < 0.01) (Fig. 3d), which suggests that the effect of YGJDSJ on anoikis in Bel-7402 cells is dependent on caspases.

Fig. 3

YGJDSJ activated caspases in Bel-7402 cells. After 24 h YGJDSJ (100–400 μg/ml) treatment, caspase-3 (a), caspase-3 (b) and caspase-9 (c) activities in suspension-cultured Bel-7402 cells were detected as described in Materials and Methods. Caspases activities were expressed as fold activation over control. d suspension-cultured Bel-7402 cells were pretreated with Z-VAD-FMK (50 μmol/L) for 2 h before treatment with YGJDSJ for 24 h, stained with Annexin V-FITC/PI and analyzed by flow cytometry. Data presented are from three separate experiments. *P < 0.01, versus control group; #P < 0.01, versus corresponding dose of YGJDSJ treated Z-VAD-FMK (−) group

YGJDSJ induces ROS production in Bel-7402 cells

It has been reported that ROS is an important mediator of anoikis and its levels increase with caspase activation [24]. In the present study, DCFH-DA staining was used to detect the ROS level. The results show that YGJDSJ significantly induced ROS generation in anchorage-independent grown Bel-7402 cells in a dose-dependent manner (P < 0.01) (Fig. 4a and b).

Fig. 4

YGJDSJ increased ROS level in Bel-7402 cells. After 24 h YGJDSJ (100–400 μg/ml) treatment, intracellular ROS production in suspension-cultured Bel-7402 cells was stained with DCFH-DA, observed under fluorescence microscope (× 200) (a), quantitated with a fluorescence microplate reader and expressed as fold of control (b)

Suspension-cultured Bel-7402 cells were pretreated with NAC (50 mmol/L for 2 h) for ROS inhibition, followed by YGJDSJ (100–400 μg/ml) treatment for 24 h, and subjected to caspase-3 (c), caspase-8 (d) and caspase-9 (e) activities and anoikis detection (f). Caspases activities were expressed as fold activation over control. Data shown are representative of three independent experiments. *P < 0.01, versus control group; #P < 0.01, versus corresponding dose of YGJDSJ treated NAC (−) group.

ROS generation was further blocked by NAC to address its role in caspases activation and anoikis. As shown in Fig. 4c-e, blocking ROS production with NAC antagonized the effect of YGJDSJ on caspase-3, − 8, and − 9 activation in Bel-7402 cells (P < 0.01). NAC also attenuated YGJDSJ induced anoikis in Bel-7402 cells (Fig. 4f) (P < 0.01). These observations suggest that ROS contributed to the effects of YGJDSJ on caspases activation and anoikis induction.

YGJDSJ inhibits PTK2 expression

Tumor cells that detach from the ECM can escape from anoikis via PTK2 activation [25]. In this study, a western blot assay was used to detect the effects of YGJDSJ on the expression and phosphorylation of PTK2 in Bel-7402 cells. As shown in Fig. 5a and b, PTK2 was highly expressed and phosphorylated in anchorage-independent Bel-7402 cells and YGJDSJ inhibited both PTK2 expression and phosphorylation in a dose-dependent manner.

Fig. 5

YGJDSJ inhibited PTK2 expression and phosphorylation in Bel-7402 cells. Suspension-cultured Bel-7402 cells were collected after YGJDSJ treatment, subjected to western blots using indicated antibodies (a), and the expression of proteins were expressed as fold of GAPDH (b). Bel-7402 cells were transfected with recombinant human PTK2 and empty vector, and subjected to suspension-culture, YGJDSJ (200 μg/ml) treatment for 24 h, western blots using indicated antibodies (c) and anoikis detection (d). *P < 0.01, versus control group; P > 0.05, versus control YGJDSJ group; #P < 0.01, versus YGJDSJ treated vector group

To examine whether down-regulation of PTK2 contribute to YGJDSJ induced anoikis, a recombinant eukaryotic expression plasmid encoding full length of human PTK2 (re-PTK2) was transfected to Bel-7402 cells. The results showed that PTK2 was over-expressed in re-PTK2 transfected Bel-7402 cells (Fig. 5c). PTK2 over-expression partially but significantly abrogated YGJDSJ induced anoikis (P < 0.01) (Fig. 5d). These observations suggested PTK2 down-regulation contributed to YGJDSJ-induced anoikis.


YGJDSJ formula was established in accordance with TCM theories and clinical medications [16, 17, 26]. We observed the basic TCM pathogenesis of liver cancer is liver Yin-deficiency and cancerous toxicity, and proposed a new therapeutic principle for liver cancer treatment, which is nourishing the liver-Yin (Yang-Gan, YG), detoxifying (Jie-Du, JD) and resolving tumor masses (Sang-Jie, SJ). Chinese herbs commonly medicated in our clinical practice with YG, JD and SJ efficacy were selected and combined as an YGJDSJ formula.

Most herbs in YGJDSJ have been confirmed to have anti-cancer effects. L. lucidum Ait. fruit (Nü-zhen-zi) is one of the most frequently used herbs in liver cancer treatment. L. lucidum Ait. fruit (Nü-zhen-zi) can inhibit proliferation, activate caspase-3, − 8 and − 9 to induce apoptosis and inhibit RB phosphorylation to promote cell senescence in hepatocellular carcinoma cells [19]. L. lucidum Ait. fruit (Nü-zhen-zi) in YGJDSJ was use for nourishing the liver-Yin.

S. nigrum L. (Long-Kui) can induce apoptosis and autophagy, and arrest the cell cycle in G2/M phase in hepatocellular carcinoma cells [27, 28]. In ovarian cancer, D. indica (Andr.) Focke (She-Mei) can promote cell apoptosis, arrest the cell cycle in the S phase, and inhibit tumor growth [29]. S. barbata D. Don (Ban-Zhi-Lian) can induce apoptosis via the mitochondrial pathway in liver cancer cells [30]. S. nigrum L. (Long-Kui), D. indica (Andr.) Focke (She-Mei) and S. barbata D. Don (Ban-Zhi-Lian) in YGJDSJ were used for detoxifying.

E. helioscopia L. (Ze-Qi) can promote apoptosis as well as inhibit growth, invasion, and metastasis of hepatocellular carcinoma [31, 32]. C. wenyujin Y. H. Chen et C. Ling (Yü-Jin) extracts can inhibit proliferation of colorectal carcinoma cells [33]. P. cuspidatum Sieb. et Zucc. (Hu-Zhang) shows anti-cancer effects against oral carcinoma, hepatocellular carcinoma, melanoma, and other tumor cells [18, 34, 35]. E. helioscopia L. (Ze-Qi), R. ternatus Thunb. (Mao-Zhua-Cao), C. wenyujin Y.H.Chen et C.Ling (Yü-Jin) and P. cuspidatum Sieb. et Zucc. (Hu-Zhang) in YGJDSJ were applied for resolving tumor masses. Thus, YGJDSJ is a modern herbal formula with anti-cancer effect in line with TCM theory. Herbs in YGJDSJ coordinate with each other in the aspect of traditional TCM efficacy. However, the additive or synergistic pharmacological effects of these herbs need further investigation.

P. cuspidatum Sieb. et Zucc. (Hu-Zhang) and D. indica (Andr.) Focke (She-Mei) have demonstrated anoikis-inducing effects in cancer cells [18, 36]. Anokis is usually investigated in cell models. Poly-HEMA coating and soft agar colony formation assays are classical anchorage-independent growth models, in which cell grow in a suspension and/or anchorage-independent manner [9, 18, 37, 38]. In the present study, it was shown that YGJDSJ inhibited the growth of Bel-7402 cells in poly-HEMA-coated plates and soft agar, which suggests that YGJDSJ can inhibit the anchorage-independent growth of Bel-7402 cells. Further EthD-1 staining and flow cytometric analysis showed that YGJDSJ could induce anoikis in Bel-7402 cells.

Anoikis is a special type of apoptosis, which is also mediated by the caspase cascade [6, 10, 23, 39]. Cells detached from the ECM can activate caspase-9 or − 8 via intrinsic or extrinsic pathways, thereby activating the apoptosis-executing protease caspase-3 and inducing anoikis. Results of this study revealed that YGJDSJ activated caspase-3, − 8, and − 9 in suspension-grown Bel-7402 cells. Z-VAD-FMK, a pan-caspase inhibitor, could abrogate the effect of YGJDSJ on anoikis in Bel-7402 cells. These findings suggest that YGJDSJ can induce Bel-7402 cell anoikis in a caspases-dependent manner via intrinsic and extrinsic apoptotic pathways.

ROS, including oxygen ions, peroxides, and oxygen-containing free radicals, is produced by cells during aerobic metabolism. High level of ROS can trigger apoptosis via intrinsic and/or extrinsic pathways [40, 41]. Natural products, such as P. cuspidatum Sieb. et Zucc. (Hu-Zhang), emodin, curcumin, and grape seed extracts, can induce anoikis in cancer cells by increasing intracellular ROS levels [11, 18, 42, 43]. In the present study, it was found that YGJDSJ induced ROS generation in Bel-7402 cells. In addition, ROS scavenger NAC could antagonize the effects of YGJDSJ on caspase-3, − 8, and- 9, and on anoikis in Bel-7402 cells. These findings suggest that ROS generation contributed to YGJDSJ activated caspases and induced anoikis.

Epithelial cells, including epithelial cancer cells, adhere to the ECM, form focal adhesion plaques mediated by integrin, and thereby promote PTK2 conformational changes and activation; this results in the production of survival signals for cell growth and proliferation through downstream signal transduction [23, 44, 45]. Detachment from ECM will result in anoikis. Cancer cells can escape anoikis by modulating PTK2 activity [25]. On the other hand, down-regulation of PTK2 expression can promote cancer cell anoikis [46, 47]. Results from this study demonstrate that YGJDSJ herbs could inhibit expression and phosphorylation of PTK2, and PTK2 overexpression could attenuate the effect of YGJDSJ on anoikis in Bel-7402 cells, suggesting that down-regulation of PTK2 contributes to YGJDSJ-induced anoikis.

It has been reported H2O2 or AKT inhibitor SC66 induced ROS can inhibit FAK (PTK2) phosphorylation [48, 49]. On the other hand, FAK inhibitor MSN-HCD may upregulate ROS level in glioma cells [50]. In addition, depression of FAK by shRNA induces apoptosis in rat osteosarcoma cells through activation of caspase-3, 7 and 9 [51]. Loss of Rb-E2F by displacement of promoters induces apoptosis through inactivation of FAK and activation of caspase-8 [52]. Doxazosin induces anoikis in prostate cancer cells via activation of caspase-3 and a reduction of FAK [53]. These observations suggest that YGJDSJ induced ROS and inhibited FAK may contribute to each other and both contribute to caspases activation.


In summary, the present study showed that YGJDSJ inhibited suspension growth of Bel-7402 cells. YGJDSJ increased ROS generation, activated caspase-3, − 8, and − 9, and down-regulated PTK2 and thus induced anoikis in Bel-7402 cells. Since anoikis is related to cancer metastasis and cell survival in blood or lymphatic circulation, the effects of YGJDSJ against hepatocarcinoma metastasis and hepatocarcinoma cells in blood or lymphatic circulation, such as circulating tumor cells, are worthy of further study.



Cell counting kit-8


2′,7′-dichlorofluorescin diacetate


Dulbecco’s modified Eagle’s medium


Extracellular matrix


Ethidium homodimer-1


Focal adhesion kinase


Fetal bovine serum


Glyceraldehyde-3-phosphate dehydrogenase




poly(2-hydroxyethyl methacrylate)


Protein tyrosine kinase 2


Reactive oxygen species


Transhepatic artery chemoembolization


Traditional Chinese medicine


Yang-Gan Jie-Du San-Jie herbal formula


  1. 1.

    Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108.

  2. 2.

    Grandhi MS, Kim AK, Ronnekleiv-Kelly SM, Kamel IR, Ghasebeh MA, Pawlik TM. Hepatocellular carcinoma: from diagnosis to treatment. Surg Oncol. 2016;25(2):74–85.

  3. 3.

    Zhuang L, Wen T, Xu M, Yang J, Wang W, Wu H, et al. Sorafenib combined with hepatectomy in patients with intermediate-stage and advanced hepatocellular carcinoma. Arch Med Sci. 2017;13(6):1383–93.

  4. 4.

    Duseja A. Staging of hepatocellular carcinoma. J Clin Exp Hepatol. 2014;4(Suppl 3):S74–9.

  5. 5.

    Yüksel Ş, Boylu Akyerli C, Cengiz Yakıcıer M. Angiogenesis, invasion, and metastasis characteristics of hepatocellular carcinoma. J Gastrointest Cancer. 2017;

  6. 6.

    Simpson CD, Anyiwe K, Schimmer AD. Anoikis resistance and tumor metastasis. Cancer Lett. 2008;272(2):177–85.

  7. 7.

    Sun B, Hu C, Yang Z, Zhang X, Zhao L, Xiong J, et al. Midkine promotes hepatocellular carcinoma metastasis by elevating anoikis resistance of circulating tumor cells. Oncotarget. 2017;8(20):32523–35.

  8. 8.

    Grossmann J. Molecular mechanisms of "detachment-induced apoptosis--Anoikis". Apoptosis. 2002;7(3):247–60.

  9. 9.

    Frisch SM, Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol. 1994;124(4):619–26.

  10. 10.

    Paoli P, Giannoni E, Chiarugi P. Anoikis molecular pathways and its role in cancer progression. Biochim Biophys Acta. 2013;1833(12):3481–98.

  11. 11.

    Terasaki M, Maeda H, Miyashita K, Mutoh M. Induction of anoikis in human colorectal cancer cells by fucoxanthinol. Nutr Cancer. 2017;69(7):1043–52.

  12. 12.

    Chang HW, Wang HC, Chen CY, Hung TW, Hou MF, Yuan SS, et al. 5-azacytidine induces anoikis, inhibits mammosphere formation and reduces metalloproteinase 9 activity in MCF-7 human breast cancer cells. Molecules. 2014;19(3):3149–59.

  13. 13.

    Zillhardt M, Park SM, Romero IL, Sawada K, Montag A, Krausz T, et al. Foretinib (GSK1363089), an orally available multikinase inhibitor of c-met and VEGFR-2, blocks proliferation, induces anoikis, and impairs ovarian cancer metastasis. Clin Cancer Res. 2011;17(12):4042–51.

  14. 14.

    Sakamoto S, Kyprianou N. Targeting anoikis resistance in prostate cancer metastasis. Mol Asp Med. 2010;31(2):205–14.

  15. 15.

    Song KJ, Jeon SK, Moon SB, Park JS, Kim JS, Kim J, et al. Lectin from Sambucus sieboldiana abrogates the anoikis resistance of colon cancer cells conferred by N-acetylglucosaminyltransferase V during hematogenous metastasis. Oncotarget. 2017;8(26):42238–51.

  16. 16.

    Hu B, Wang SS, Du Q. Traditional Chinese medicine for prevention and treatment of hepatocarcinoma: from bench to bedside. World J Hepatol. 2015;7(9):1209–32.

  17. 17.

    Hu B, An HM, Wang SS, Chen JJ, Xu L. Preventive and therapeutic effects of Chinese herbal compounds against hepatocellular carcinoma. Molecules. 2016;21(2):142.

  18. 18.

    Hu B, An HM, Shen KP, Song HY, Deng S. Polygonum cuspidatum extract induces anoikis in hepatocarcinoma cells associated with generation of reactive oxygen species and downregulation of focal adhesion kinase. Evid Based Complement Alternat Med. 2012;2012:607675.

  19. 19.

    Hu B, Du Q, Deng S, An HM, Pan CF, Shen KP, et al. Ligustrum lucidum Ait. Fruit extract induces apoptosis and cell senescence in human hepatocellular carcinoma cells through upregulation of p21. Oncol Rep. 2014;32(3):1037–42.

  20. 20.

    Smith JA, Weidemann MJ. Further characterization of the neutrophil oxidative burst by flow cytometry. J Immunol Methods. 1993;162(2):261–8.

  21. 21.

    Hu B, Shen KP, An HM, Wu Y, Du Q. Aqueous extract of Curcuma aromatica induces apoptosis and G2/M arrest in human colon carcinoma LS-174-T cells independent of p53. Cancer Biother Radiopharm. 2011;26(1):97–104.

  22. 22.

    Hu B, An HM, Shen KP, Xu L, Du Q, Deng S, et al. Modified Yi guan Jian, a Chinese herbal formula, induces anoikis in Bel-7402 human hepatocarcinoma cells in vitro. Oncol Rep. 2011;26(6):1465–70.

  23. 23.

    Chiarugi P, Giannoni E. Anoikis: a necessary death program for anchorage-dependent cells. Biochem Pharmacol. 2008;76(11):1352–64.

  24. 24.

    Li AE, Ito H, Rovira II, Kim KS, Takeda K, Yu ZY, et al. A role for reactive oxygen species in endothelial cell anoikis. Circ Res. 1999;85(4):304–10.

  25. 25.

    Liu G, Meng X, Jin Y, Bai J, Zhao Y, Cui X, et al. Inhibitory role of focal adhesion kinase on anoikis in the lung cancer cell A549. Cell Biol Int. 2008;32(6):663–70.

  26. 26.

    Du Q, Hu B, Shen KP. Pathogenesis and treatment of hepatocellular carcinoma in traditional Chinese medicine. World J Integr Trad West Med. 2010;5(9):814–7. Chinese

  27. 27.

    Lin HM, Tseng HC, Wang CJ, Chyau CC, Liao KK, Peng PL, et al. Induction of autophagy and apoptosis by the extract of Solanum nigrum Linn in HepG2 cells. J Agric Food Chem. 2007;55(9):3620–8.

  28. 28.

    Wang HC, Chung PJ, Wu CH, Lan KP, Yang MY, Wang CJ. Solanum nigrum L. polyphenolic extract inhibits hepatocarcinoma cell growth by inducing G2/M phase arrest and apoptosis. J Sci Food Agric. 2011;91(1):178–85.

  29. 29.

    Peng B, Hu Q, Liu X, Wang L, Chang Q, Li J, et al. Duchesnea phenolic fraction inhibits in vitro and in vivo growth of cervical cancer through induction of apoptosis and cell cycle arrest. Exp Biol Med (Maywood). 2009;234(1):74–83.

  30. 30.

    Gao J, Lu WF, Dai ZJ, Lin S, Zhao Y, Li S, et al. Induction of apoptosis by total flavonoids from Scutellaria barbata D. Don in human hepatocarcinoma MHCC97-H cells via the mitochondrial pathway. Tumour Biol. 2014;35(3):2549–59.

  31. 31.

    Cheng J, Han W, Wang Z, Shao Y, Wang Y, Zhang Y, et al. Hepatocellular carcinoma growth is inhibited by Euphorbia helioscopia L. extract in nude mice xenografts. Biomed Res Int. 2015;2015:601015.

  32. 32.

    Wang ZY, Liu HP, Zhang YC, Guo LQ, Li ZX, et al. Anticancer potential of Euphorbia helioscopia L extracts against human cancer cells. Anat Rec (Hoboken). 2012;295(2):223–33.

  33. 33.

    Wang X, Jiang Y, Hu D. Optimization and in vitro antiproliferation of Curcuma wenyujin's active extracts by ultrasonication and response surface methodology. Chem Cent J. 2016;10:32.

  34. 34.

    Shin JA, Shim JH, Jeon JG, Choi KH, Choi ES, Cho NP, et al. Apoptotic effect of Polygonum Cuspidatum in oral cancer cells through the regulation of specificity protein 1. Oral Dis. 2011;17(2):162–70.

  35. 35.

    Lee CC, Chen YT, Chiu CC, Liao WT, Liu YC, David Wang HM. Polygonum cuspidatum extracts as bioactive antioxidaion, anti-tyrosinase, immune stimulation and anticancer agents. J Biosci Bioeng. 2015;119(4):464–9.

  36. 36.

    Hu B, Shen KP, Shi XF, Deng S, Wei MM. An experimental study on effects of Duchesnea indica on anoikis in human colonic carcinoma RKO cells. World J Integr Trad West Med. 2013;8(1):69–72. Chinese.

  37. 37.

    Bretland AJ, Lawry J, Sharrard RM. A study of death by anoikis in cultured epithelial cells. Cell Prolif. 2001;34(4):199–210.

  38. 38.

    Sakamoto S, McCann RO, Dhir R, Kyprianou N. Talin1 promotes tumor invasion and metastasis via focal adhesion signaling and anoikis resistance. Cancer Res. 2010;70(5):1885–95.

  39. 39.

    Coates JM, Galante JM, Bold RJ. Cancer therapy beyond apoptosis: autophagy and anoikis as mechanisms of cell death. J Surg Res. 2010;164(2):301–8.

  40. 40.

    Circu ML, Aw TY. Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic Biol Med. 2010;48(6):749–62.

  41. 41.

    Lau AT, Wang Y, Chiu JF. Reactive oxygen species: current knowledge and applications in cancer research and therapeutic. J Cell Biochem. 2008;104(2):657–67.

  42. 42.

    Cai J, Niu X, Chen Y, Hu Q, Shi G, Wu H, et al. Emodin-induced generation of reactive oxygen species inhibits RhoA activation to sensitize gastric carcinoma cells to anoikis. Neoplasia. 2008;10(1):41–51.

  43. 43.

    Kaur M, Agarwal R, Agarwal C. Grape seed extract induces anoikis and caspase-mediated apoptosis in human prostate carcinoma LNCaP cells: possible role of ataxia telangiectasia mutated-p53 activation. Mol Cancer Ther. 2006;5(5):1265–74.

  44. 44.

    Nagaprashantha LD, Vatsyayan R, Lelsani PC, Awasthi S, Singhal SS. The sensors and regulators of cell-matrix surveillance in anoikis resistance of tumors. Int J Cancer. 2011;128(4):743–52.

  45. 45.

    Zouq NK, Keeble JA, Lindsay J, Valentijn AJ, Zhang L, Mills D, et al. FAK engages multiple pathways to maintain survival of fibroblasts and epithelia: differential roles for paxillin and p130Cas. J Cell Sci. 2009;122(Pt 3):357–67.

  46. 46.

    Duxbury MS, Ito H, Zinner MJ, Ashley SW, Whang EE. Focal adhesion kinase gene silencing promotes anoikis and suppresses metastasis of human pancreatic adenocarcinoma cells. Surgery. 2004;135(5):555–62.

  47. 47.

    Casanova I, Parreño M, Farré L, Guerrero S, Céspedes MV, Pavon MA, et al. Celecoxib induces anoikis in human colon carcinoma cells associated with the deregulation of focal adhesions and nuclear translocation of p130Cas. Int J Cancer. 2006;118(10):2381–9.

  48. 48.

    Song H, Cha MJ, Song BW, Kim IK, Chang W, Lim S, et al. Reactive oxygen species inhibit adhesion of mesenchymal stem cells implanted into ischemic myocardium via interference of focal adhesion complex. Stem Cells. 2010;28(3):555–63.

  49. 49.

    Cusimano A, Puleio R, D’Alessandro N, Loria GR, McCubrey JA, Montalto G, et al. Cytotoxic activity of the novel small molecule AKT inhibitor SC66 in hepatocellular carcinoma cells. Oncotarget. 2015;6(3):1707–22.

  50. 50.

    Thiyagarajan V, Lin SX, Lee CH, Weng CF. A focal adhesion kinase inhibitor 16-hydroxy-cleroda-3,13-dien-16,15-olide incorporated into enteric-coated nanoparticles for controlled anti-glioma drug delivery. Colloids Surf B Biointerfaces. 2016;141:120–31.

  51. 51.

    Yang S, Wang L, Kong Q. Depression of focal adhesion kinase induces apoptosis in rat osteosarcoma OSR-6 cells in a caspase-dependent pathway. Cell Biochem Biophys. 2014;70(2):765–70.

  52. 52.

    Lieman JH, Worley LA, Harbour JW. Loss of Rb-E2F repression results in caspase-8-mediated apoptosis through inactivation of focal adhesion kinase. J Biol Chem. 2005;280(11):10484–90.

  53. 53.

    Walden PD, Globina Y, Nieder A. Induction of anoikis by doxazosin in prostate cancer cells is associated with activation of caspase-3 and a reduction of focal adhesion kinase. Urol Res. 2004;32(4):261–5.

Download references


Not applicable.


This study was supported by Program from Science & Technology Commission of Shanghai Municipality (16401902500), and Three-year Action Program of Shanghai Municipality for Traditional Chinese Medicine (ZY3-CCCX-3-3025).

Availability of data and materials

All data and materials are contained and described in the main paper.

Author information

BH conceived and designed the study. BH, TZ, HMA, JLZ, XY and XWH carried out the experiment. HMA analyzed the data. BH drafted and revised the manuscript. All authors read and approved the final manuscript.

Correspondence to Bing Hu.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark


  • Hepatocellular carcinoma
  • Chinese herb
  • Anoikis
  • Caspases
  • Reactive oxygen species
  • Protein tyrosine kinase 2